semaglutide drug mounjaro weight loss could outpace Ozempic Ozempic, Mounjaro manufacturers sued over

Given the increased appreciation of the reciprocal nature of dyslipidemia, obesity, dysglycemia and liver disease, including nonalcoholic fatty liver disease (NAFLD) and traditional risk factors, a new classification of metabolic (dysfunction) associated fatty liver disease (MAFLD) has emerged (3)

doi: 10.3390/nu7042801

Lets dive into the science and practical advice to help you make an informed decision

The human gut microbiota represents a highly heterogeneous consortium of microorganisms, encompassing bacteria, archaea, viruses, and fungi, which coexist in a dynamic equilibrium with the host (Nazir et al., 2024)